SCHEMBL4904079

SCHEMBL4904079

O=C(CCN1C(=O)c2ccccc2C1=O)Nc1cc(-c2ccccc2)ccc1O.O=C1c2ccccc2C(=O)N1CCc1nc2cc(-c3ccccc3)ccc2o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
MAPT P10636 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 3/20 0.50
HPGD P15428 2/20 0.50
PPARG P37231 1/20 0.50
NCOA2 Q15596 1/20 0.50
NCOA1 Q15788 1/20 0.50
HDAC1 Q13547 1/20 0.46
HSD17B10 Q99714 1/20 0.43
AKR1B1 P15121 1/20 0.42
PTPN1 P18031 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4903696 0.85 MEN1 (0.45) MEN1KMT2AMAPTSMN1; SMN2NPC1
SCHEMBL4905954 0.84 PDE10A (0.48) MEN1KMT2AMAPTSMN1; SMN2NPC1
SCHEMBL22042895 0.72 RXRA (0.55) KDM4EHPGDAKR1B1L3MBTL1CYP3A4
SCHEMBL4903614 0.71 ALDH1A1 (0.54) MEN1KMT2AMAPTSMN1; SMN2NPC1
SCHEMBL4905835 0.71 PKM (0.48) MAPTSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL4906117 0.70 MAPT (0.60) MEN1KMT2AMAPTSMN1; SMN2NPC1
SCHEMBL4897967 0.68 MAPT (0.44) KMT2AMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL4906852 0.68 MEN1 (0.58) MEN1KMT2AMAPTSMN1; SMN2ALDH1A1
SCHEMBL11336489 0.68 AKR1B1 (0.61) KDM4EAKR1B1L3MBTL1TSHR
SCHEMBL4905806 0.64 LOXL2 (0.64) MEN1KMT2AMAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MEN1 4859/4885KMT2A 3602/4885MAPT 1858/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885MAPT 1786/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885MAPT 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.